Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

References

• GuoWTanHYWangNWangXFengYDeciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluationCancer Manag Res20181071573429692630
   PubMed Web of Science ®Google Scholar
• HanLLLvYGuoHRuanZPNanKJImplications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyWorld J Gastroenterol20142030102491026125132742
   PubMed Web of Science ®Google Scholar
• ChenDZhangCLinJSongXWangHScreening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinomaCancer Manag Res2018101275128329849467
   PubMed Web of Science ®Google Scholar
• GuoHWuTLuQSurgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stagesCancer Manag Res20181036136929503583
   PubMed Web of Science ®Google Scholar
• YuanJHYangFWangFA long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinomaCancer Cell201425566668124768205
   PubMed Web of Science ®Google Scholar
• XiaoYBCaiSHLiuLLYangXYunJPDecreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinomaCancer Manag Res2018101781178929983595
   PubMed Web of Science ®Google Scholar
• SafiriSKhazaeiSMansoriKAyubiEComments on “Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis”Hepatology20176641358135928727154
   PubMed Web of Science ®Google Scholar
• KangHJJungSKKimSJChungSJStructure of human alpha-enolase (hENO1), a multifunctional glycolytic enzymeActa Crystallogr D Biol Crystallogr200864Pt 665165718560153
   PubMedGoogle Scholar
• LeonardPGSataniNMaxwellDSF2312 is a natural phosphonate inhibitor of enolaseNat Chem Biol201612121053105827723749
   PubMed Web of Science ®Google Scholar
• ChuNJArmstrongTDJaffeeEMNonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunopreventionClin Cancer Res20152171549155725623216
   PubMed Web of Science ®Google Scholar
• CappelloPRollaSChiarleRVaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancerGastroenterology201314451098110623333712
   PubMed Web of Science ®Google Scholar
• SanchezTWZhangGLiJImmunoseroproteomic profiling in African American men with prostate cancer: evidence for an autoantibody response to glycolysis and plasminogen-associated proteinsMol Cell Proteomics201615123564358027742740
   PubMed Web of Science ®Google Scholar
• QingSTulakeWRuMProteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infectionTumour Biol2017394101042831769754710104283176975428443473
   PubMedGoogle Scholar
• LiuYLiHLiuYZhuZMiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cellsBiomed Pharmacother201810580581229913409
   PubMed Web of Science ®Google Scholar
• PrincipeMBorgoniSCascioneMAlpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasisJ Hematol Oncol20171011628086938
   PubMedGoogle Scholar
• TakashimaMKuramitsuYYokoyamaYOverexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysisProteomics2005561686169215800975
   PubMed Web of Science ®Google Scholar
• HamaguchiTIizukaNTsunedomiRGlycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinomaInt J Oncol200833472573118813785
   PubMed Web of Science ®Google Scholar
• HeYChenXYuYLDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinomaMol Carcinog201857677278329569755
   PubMed Web of Science ®Google Scholar
• European Association for The Study of the LiverEuropean Organisation for Research and Treatment of CancerLiver EEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• GaoJZhaoRXueYRole of enolase-1 in response to hypoxia in breast cancer: exploring the mechanisms of actionOncol Rep20132941322133223381546
   PubMed Web of Science ®Google Scholar
• FuQFLiuYFanYAlpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathwayJ Hematol Oncol201582225887760
   PubMed Web of Science ®Google Scholar
• YangJZhouMZhaoRIdentification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysisJ Proteomics201410916217524998431
   PubMed Web of Science ®Google Scholar
• SongYLuoQLongHAlpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in gliomaMol Cancer2014136524650096
   PubMed Web of Science ®Google Scholar
• ChenSZhangYWangHWW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in gliomaCell Death Dis20189334729497031
   PubMedGoogle Scholar
• ChangGCLiuKJHsiehCLIdentification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomesClin Cancer Res200612195746575417020980
   PubMed Web of Science ®Google Scholar
• FeldtMBjarnadottirOKimbungSStatin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trialJ Transl Med20151313325925673
   PubMed Web of Science ®Google Scholar
• ZhuYGuJLiYMiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexesCancer Lett2018412596828987387
   PubMed Web of Science ®Google Scholar
• HillJWTansavatdiKLockettKLValidation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer riskCancer Manag Res20091394821188122
   PubMedGoogle Scholar
• MaaloufKBaydounERizkSKefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytesCancer Manag Res20113394721448298
   PubMedGoogle Scholar
• OttoTSicinskiPCell cycle proteins as promising targets in cancer therapyNat Rev Cancer20171729311528127048
   PubMed Web of Science ®Google Scholar
• LuoYHurwitzJMassaguéJCell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature199537565271591617753174
   PubMed Web of Science ®Google Scholar
• YangCKYuTDHanCYGenome-wide association study of MKI67 expression and its clinical implications in HBV-related hepatocellular Carcinoma in Southern ChinaCell Physiol Biochem20174241342135728700999
   PubMedGoogle Scholar